Results of a Phase II Trial of Cetuximab plus Capecitabine/Irinotecan as First-Line Therapy for Patients with Advanced and/or Metastatic Colorectal Cancer by Cartwright, Thomas, Kuefler, Paul, Cohn, Allen, Hyman, William, Berger, Maury, Richards, Donald, Vukelja, Svetislava, Nugent, John E, Ruxer, Robert L, Boehm, Kristi A, Asmar, Lina

Get full text

Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium by Hutson, Thomas E., Vukelja, Svetislava, Atienza, Daniel, Awasthi, Sanjay, Delaune, Robert, Deutsch, Margaret, Dien, Philip Y., Gregory, Thomas F., Kolodziej, Michael J., Muscato, Joseph J., Raju, Robert N., Ruxer, Robert L., Mull, Stephanie, Ilegbodu, Des, Hood, Karen, Nicol, Steven, Berry, William

Get full text

Pemetrexed in Relapsed Small-Cell Lung Cancer and the Impact of Shortened Vitamin Supplementation Lead-In Time: Results of a Phase II Trial by Socinski, Mark A., Raju, Robert N., Neubauer, Marcus, Smith, David A., Richards, Donald A., Savin, Michael, Ruxer, Robert L., Reynolds, Craig H., Zhan, Feng, Bromund, Jane L., Chen, Ruqin, Obasaju, Coleman

Get full text

Mesothelioma following Wilms' tumor in childhood by Antman, Karen H., Ruxer, Robert L., Aisner, Joseph, Vawter, Gordon

Get full text

Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients by Joshi, J H, Newman, K A, Brown, B W, Finley, R S, Ruxer, R L, Moody, M A, Schimpff, S C

Get full text

Double ?-lactam regimen compared to an aminoglycoside/?-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients by Joshi, Jai H., Newman, Kathryn A., Brown, Bary W., Finley, Rebecca S., Ruxer, Robert L., Moody, Mark A., Schimpff, Stephen C.

Get full text